For more than a decade, PTC Therapeutics has been going back and forth with the FDA to find a path forward for a Duchenne muscular dystrophy drug with a spotty track record in clinical testing. That ...
PTC Therapeutics faces significant risks with its key revenue sources, Translarna and Emflaza, amid regulatory challenges and generic competition. Despite a strong cash position, PTC's heavy losses ...
Metrolink unveiled its fully equipped Positive Train Control (PTC) test train at an event hosted by Metrolink Board Chair Richard Katz and the Metrolink Board. Participants included Los Angeles Mayor ...
The Averna ConnexThing Toolkits accelerate the deployment of IoT solutions with ThingWorx MONTREAL, Feb. 5, 2019 /PRNewswire/ -- Averna, a Test & Quality Solutions provider and PTC ThingWorx Platinum ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results